Gapping up
In reaction to strong earnings/guidance: OTEX +7.6% (also announces 2:1 split), JNPR +5.7% (also reports indicate Jana Partners planning on taking a stake, upgraded to Outperform from Mkt Perform at William Blair, upgraded to Neutral from Sell at Goldman, upgraded to Overweight from Equal Weight at Barclays ), MSCC +3.5% (light volume), ALTR +3.2%, DFS +3.1%, MSFT +2.9%, LEG +2.3%, (light volume), SWK +1.7%, (light volume), BMY +1.7%, KMB +1% (light volume), CBST +1%, SBUX +0.8%, KLAC +0.7%, PG +0.6%.
M&A news: MCK +3.3% (announces agreement with Franz Haniel & Cie. GmbH to acquire entire holding of Celesio shares at EUR 23.50 per share).
Select metals stocks trading higher: GOLD +2.4%, GDX +2%, GFI +2%, KGC +1.9%, ABX +1.5%, HL +1.5%, GG +1.4%, SLW +1.2%, SLV +1.2%, .
Other news: BDSI +28% and ENDP +2.5% (Endo Health and BioDeliver Sciences announce positive Top-Line Results from the Phase III Clinical Trial of BEMA Buprenorphine in Opioid Naive Patients with Chronic Pain), ADMP +9.7% (receives notice of key allowance for US Patent that supports its cancer immunology portfolio), ASML +2% (still checking), INFI +1.8% (reports phase 1 data of IPI-145 at sixth annual t-cell lymphoma forum; 38% response rate in patients with t-cell lymphomas, suggesting broad potential of IPI-145 in blood cancers), SNE +1.8% (may be attributed to MSFT upside in game console sales).
Analyst comments: ANGI +1.5% (upgraded to Buy from Neutral at B. Riley & Co), NOK +0.4% (upgraded to Buy from Hold at Societe Generale)